Clinical study of intraperitoreal immune chemotherapy for colorectal cancer following radical operation
10.3760/cma.j.issn.1008-6706.2009.02.005
- VernacularTitle:大肠癌根治术后腹腔免疫治疗的临床研究
- Author:
Yijie ZHANG
;
Yuan LIANG
;
Zhixin HE
;
Duoyang CHEN
;
Keqin LI
- Publication Type:Journal Article
- Keywords:
Colorectal neoplasms;
Chemotherapy,Cancer,regional peffusion;
Immunotherapy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2009;16(2):201-202
- CountryChina
- Language:Chinese
-
Abstract:
Objective To Research the efficacy and side effects of intra-abdominal chemotherapy immune to the abdominal cavity after colorectal cancer liver metastasis and local recurrence.Methods 172 eases of colorectal cancer patients after radical operation were randomly divided into conventional regulation 86 cases of abdominal chemotherapy group(control group) and the immune abdominal chemotherapy group of 86 cases(observation group).The control group received 5-FU1.0,MMC8mg intraperitoneal chemotherapy The observation group at the grass-rcots level to add IL-2 50 million U.Results Observation group effective rate .was 70.9% higher than 55.8% (P ＜0.05) ;the obsenation gionp the three-year survival rate 83.7%,dlsease-free survival rate was 44.2% higher than the 62.8%,22.1% (P＜0.05) ;observation group three-year recurrence rate of 25.6% and 34.9% lower than the rate of liver metastases in the control group of 37.8%,48.9% (P＜0.05) ;two groups of gastrointestinal reaction,ⅠⅡ or degree of bone marrow suppression,liver function mildly abnormal ( elevated alanine amiuotransferase) had no difference.Conclusion For advanced colorectal cancer patients with early immune abdominal chemotherapy,the effective prevention and treatment of abdominal cavity and liver metastasis planting to improve the survival rate,side effects of light,fewer complications,the extension of survival,worthy of clinical application.
